Precision Cancer Diagnostics: Tracking Genomic Evolution in Clinical Trials

envie a um amigo share this

Precision Cancer Diagnostics: Tracking Genomic Evolution in Clinical Trials

Quarta, 07.12.2016

Francisco Beça: Department of Pathology and Cancer Research Institute, Beth Israel Deaconess Cancer Center, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

Andrew H. Beck: Department of Pathology and Cancer Research Institute, Beth Israel Deaconess Cancer Center, Boston, Massachusetts, United States of America, Harvard Medical School, Boston, Massachusetts, United States of America

PLoS Medicine

http://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.1002177